Value Line, Inc. (NASDAQ – VALU) announced today that its Board of Directors declared on July 17, 2026 a quarterly cash dividend of $0.35 per common share, payable on August 11, 2026, to stockholders ...

From the Art Gallery to Technical Workshops, the conference explores how artificial intelligence augments the work of artists ...

The company has drawn governments, a major chipmaker, and the Pentagon into an effort to control fragile photons and build a ...

Rings of Power Season 3 arrives November 11 on Prime Video. The Hall H panel on July 24 is the first public showcase for cast ...

As China's first NMPA Class III-certified hair transplant robot, HAIRO integrates artificial intelligence, computer vision ...

Germany's Fraunhofer Institute for Laser Technology delivered a milestone this week that sits at the intersection of precision optics and quantum hardware: a fully assembled, commissioned laser ...

CMS floats Medicare payment for AI diagnostic software, proposing a new category to standardize reimbursement for algorithm-driven clinical tools.

OpenAI could set the stage for a trio of trillion-dollar-valuation companies debuting rapidly, which together are seen as the most consequential test of investor appetite for high-growth technology ...

Purdue Extension is responsible for 4-H within the state of Indiana. Purdue Extension collaborates with the county 4-H affiliates (4-H Council and/or Fair Board) for developing 4-H programming and ...

The launch of Novo’s Wegovy pill, which began in early January, has become a turning point in the treatment of obesity. Injectable GLP-1 medicines for weight loss have been around for nearly nine ...

Jan 14 (Reuters) - Structure Therapeutics' (GPCR.O), opens new tab CEO expects oral weight-loss pills to capture as much as half of the GLP-1 market by 2030, driven partly by pent-up demand from ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...